- Home
- BLFY vs APLT Comparison
BLFY vs APLT Comparison
Compare BLFY & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLFY
- APLT
- Stock Information
- Founded
- BLFY 1939
- APLT 2016
- Country
- BLFY United States
- APLT United States
- Employees
- BLFY N/A
- APLT N/A
- Industry
- BLFY Commercial Banks
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- BLFY Finance
- APLT Health Care
- Exchange
- BLFY Nasdaq
- APLT Nasdaq
- Market Cap
- BLFY 191.7M
- APLT 178.6M
- IPO Year
- BLFY N/A
- APLT 2019
- Fundamental
- Price
- BLFY $8.84
- APLT $1.06
- Analyst Decision
- BLFY Hold
- APLT Buy
- Analyst Count
- BLFY 1
- APLT 5
- Target Price
- BLFY $10.00
- APLT $4.13
- AVG Volume (30 Days)
- BLFY 49.2K
- APLT 11.4M
- Earning Date
- BLFY 10-22-2025
- APLT 11-06-2025
- Dividend Yield
- BLFY N/A
- APLT N/A
- EPS Growth
- BLFY N/A
- APLT N/A
- EPS
- BLFY N/A
- APLT N/A
- Revenue
- BLFY $41,939,000.00
- APLT $121,000.00
- Revenue This Year
- BLFY $21.08
- APLT N/A
- Revenue Next Year
- BLFY $17.38
- APLT $5,931.24
- P/E Ratio
- BLFY N/A
- APLT N/A
- Revenue Growth
- BLFY 0.22
- APLT N/A
- 52 Week Low
- BLFY $8.24
- APLT $0.30
- 52 Week High
- BLFY $11.38
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- BLFY 42.61
- APLT 64.62
- Support Level
- BLFY $8.71
- APLT $0.56
- Resistance Level
- BLFY $9.55
- APLT $1.32
- Average True Range (ATR)
- BLFY 0.30
- APLT 0.16
- MACD
- BLFY -0.07
- APLT 0.05
- Stochastic Oscillator
- BLFY 19.00
- APLT 67.00
About BLFY Blue Foundry Bancorp
Blue Foundry Bancorp is a full-service bank. Its business consists of originating one-to-four-family residential, multi-family, and non-residential real estate mortgages, home equity loans and lines of credit, and commercial and industrial loans. It attracts retail deposits from the general public in the areas surrounding its banking offices, through its borrowers, and through its online presence, offering a wide variety of deposit products. The bank also invests in securities. Its revenues are derived from interest on loans and, to a lesser extent, interest on mortgage-backed and other investment securities. The company's sources of funds are deposits, principal, and interest payments on loans, securities, and borrowings from the Federal Home Loan Bank of New York.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.